Finance

Lists
Why is ONCOZ up 6.46%?
Dive Deeper
ONCOZ:STO
Oncozenge AB
SEK 3.46
+6.46%
(+0.21) 1D
Oct 16, 5:00:00 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ONCOZ...
Open
SEK 3.29
High
SEK 3.48
Low
SEK 3.24
Mkt. cap
91.69M
Avg. vol.
61.76K
Volume
52.70K
52-wk high
SEK 8.58
52-wk low
SEK 3.10
EPS
-SEK 1.47
Shares outstanding
26.50M
No. of employees
1
Open
SEK 3.29
High
SEK 3.48
Low
SEK 3.24
Mkt. cap
91.69M
Avg. vol.
61.76K
Volume
52.70K
52-wk high
SEK 8.58
52-wk low
SEK 3.10
EPS
-SEK 1.47
Shares outstanding
26.50M
No. of employees
1
News stories
From web sources and news partners
About Oncozenge AB
CEOPaul de Potocki
Employees1
Founded2020
Headquarters-
SectorPharmaceutical industry
Websiteoncozenge.com
Previous reportsAll values in SEK
Loading Previous Earnings...
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.00K
1.00K
-
5.96M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.48M
9.75M
6.80M
11.25M
Operating expense
3.48M
9.75M
6.80M
11.40M
Total operating expenses
3.48M
9.75M
6.80M
11.40M
Operating income
-3.48M
-9.75M
-6.80M
-5.44M
Other non operating income
-
-
-
-
EBT including unusual items
-3.49M
-9.89M
-7.13M
-5.67M
EBT excluding unusual items
-3.49M
-9.89M
-7.13M
-5.67M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
2.00K
-
2.00K
150.00K
Net income
-3.49M
-9.89M
-7.13M
-5.67M
Net profit margin
-174,550.00%
-988,600.00%
-
-95.04%
Earnings per share
-
-
-
-
Interest and investment income
1.00K
15.00K
-
-
Interest expense
-13.00K
-154.00K
-330.00K
-226.00K
Net interest expenses
-12.00K
-139.00K
-330.00K
-226.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps